Neighbor News
Fish & Richardson Announces Silicon Valley Principal Named 2016 “Life Science Star” by LMG Life Sciences
Five other Fish attorneys and firm's Life Sciences practice also receive top rankings

Fish & Richardson announced today principal Dr. Teresa Lavoie, an attorney based in the firm’s Silicon Valley office, has been named a “Life Science Star” for 2016 in the fifth annual edition of LMG Life Sciences.
Firm principals Gwilym Attwell, Juanita Brooks, Dr. Janis Fraser, Terry Mahn,and Jonathan Singer were also named “Life Science Stars.” One client noted that Fish attorneys possess “exceptional skills as patent litigation trial counsel” and “get the importance of being a good partner.”
The firm’s Life Sciences practice also received top rankings. Fish was “Highly Recommended” for Patent Prosecution, Patent Strategy and Management, and General Patent Litigation and “Recommended” for Hatch-Waxman Patent Litigation (Branded). Fish also was named a finalist at the LMG Life Sciences Awards 2016 for General Patent Litigation Firm of the Year and Inter-Partes Review Firm of the Year.
Find out what's happening in Redwood City-Woodsidefor free with the latest updates from Patch.
The annual awards recognize the leading attorneys, law firms, and in-house counsel teams that have played a significant role in the life sciences industry over the last 12 months.
Fish’s Life Sciences group works with large and small companies, along with academic and research institutions, to protect their most valuable innovations. The firm offers biotechnology and pharmaceutical clients a wide range of services, including patent prosecution and portfolio management, strategic counseling and opinions, and licensing and agreements; representation in post-grant proceedings before the Patent Trial and Appeal Board; counsel on FDA regulation and patent exclusivity; and litigation, including representation in Hatch-Waxman cases.
Find out what's happening in Redwood City-Woodsidefor free with the latest updates from Patch.
The Legal Media Group publishes the LMG Life Sciences guide annually in association with Euromoney Institutional Investor. The guide is based on nearly 1,000 interviews and surveys completed by partners active in the market, interviews with clients and leading lawyers, and a review of public information.